Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GREEN, Andrew R")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 42

  • Page / 2
Export

Selection :

  • and

SHON Is a Novel Estrogen-Regulated Oncogene in Mammary Carcinoma That Predicts Patient Response to Endocrine TherapyYEWON JUNG; ABDEL-FATAH, Tarek M. A; LONGXIN CHEN et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 23, pp 6951-6962, issn 0008-5472, 12 p.Article

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosisALESKANDARANY, Mohammed A; RAKHA, Emad A; AHMED, Mohamed A. H et al.Breast cancer research and treatment. 2010, Vol 122, Num 1, pp 45-53, issn 0167-6806, 9 p.Article

Expression of BRCA1 protein in breast cancer and its prognostic significanceRAKHA, Emad A; EL-SHEIKH, Somaia E; KANDIL, Mona A et al.Human pathology. 2008, Vol 39, Num 6, pp 857-865, issn 0046-8177, 9 p.Article

Invasive lobular carcinoma of the breast : Response to hormonal therapy and outcomesRAKHA, Emad A; EL-SAYED, Maysa E; LEE, Andrew H. S et al.European journal of cancer (1990). 2008, Vol 44, Num 1, pp 73-83, issn 0959-8049, 11 p.Article

Prognostic markers in triple-negative breast cancerRAKHA, Emad A; EL-SAYED, Maysa E; GREEN, Andrew R et al.Cancer. 2007, Vol 109, Num 1, pp 25-32, issn 0008-543X, 8 p.Article

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importanceRAKHA, Emad A; ABD EL-REHIM, Dalia; PAISH, Claire et al.European journal of cancer (1990). 2006, Vol 42, Num 18, pp 3149-3156, issn 0959-8049, 8 p.Article

Characteristics of basal cytokeratin expression in breast cancerALSHAREEDA, Alaa T; SORIA, Daniele; GARIBALDI, Jonathan M et al.Breast cancer research and treatment. 2013, Vol 139, Num 1, pp 23-37, issn 0167-6806, 15 p.Article

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancersNATRAJAN, Rachael; MACKAY, Alan; POPOVA, Tatiana et al.Journal of pathology (Print). 2012, Vol 227, Num 1, pp 29-41, issn 0022-3417, 13 p.Article

Differential oestrogen receptor binding is associated with clinical outcome in breast cancerROSS-INNES, Caryn S; STARK, Rory; ALI, Simak et al.Nature (London). 2012, Vol 481, Num 7381, pp 389-393, issn 0028-0836, 5 p.Article

Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancerALESKANDARANY, Mohammed A; RAKHA, Emad A; AHMED, Mohamed A et al.Breast cancer research and treatment. 2011, Vol 127, Num 2, pp 407-416, issn 0167-6806, 10 p.Article

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancerONSY HABASHY, Hany; RAKHA, Emad A; ALESKANDARANY, Mohammed et al.Breast cancer research and treatment. 2011, Vol 129, Num 1, pp 11-21, issn 0167-6806, 11 p.Article

Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the BreastRAKHA, Emad A; PATEL, Arjun; POWE, Des G et al.The American journal of surgical pathology. 2010, Vol 34, Num 10, pp 1472-1479, issn 0147-5185, 8 p.Article

Growth fraction as a predictor of response to chemotherapy in node-negative breast cancerALESKANDARANY, Mohammed A; GREEN, Andrew R; ELLIS, Ian O et al.International journal of cancer (Print). 2010, Vol 126, Num 7, pp 1761-1769, issn 0020-7136, 9 p.Article

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenONSY HABASHY, Hany; POWE, Desmond G; ELLIS, Ian O et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 283-293, issn 0167-6806, 11 p.Article

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient OutcomeELSHEIKH, Somaia E; GREEN, Andrew R; GRAINGE, Matthew J et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 9, pp 3802-3809, issn 0008-5472, 8 p.Article

Poor-Prognosis Estrogen Receptor-Positive Breast Cancer Identified by Histopathologic SubclassificationWEBSTER, Lucy R; LEE, Shu-Fen; GREEN, Andrew R et al.Clinical cancer research (Print). 2008, Vol 14, Num 20, pp 6625-6633, issn 1078-0432, 9 p.Article

C-Met in Invasive Breast Cancer: Is There a Relationship With the Basal-Like Subtype?HO-YEN, Colan M; GREEN, Andrew R; RAKHA, Emad A et al.Cancer. 2014, Vol 120, Num 2, pp 163-171, issn 0008-543X, 9 p.Article

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcomeSTEBBING, Justin; FILIPOVIC, Aleksandra; ELLIS, Ian O et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 537-544, issn 0167-6806, 8 p.Article

TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcomeALESKANDARANY, Mohammed A; NEGM, Ola H; RAKHA, Emad A et al.Breast cancer research and treatment. 2012, Vol 136, Num 2, pp 419-427, issn 0167-6806, 9 p.Article

CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosisALBASRI, Abdulkader; ALESKANDARANY, Mohammed; BENHASOUNA, Ahmed et al.Breast cancer research and treatment. 2011, Vol 126, Num 1, pp 47-54, issn 0167-6806, 8 p.Article

Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breastFERNANDEZ, Beatriz; PAISH, E. Claire; GREEN, Andrew R et al.Journal of clinical pathology. 2011, Vol 64, Num 11, pp 995-1000, issn 0021-9746, 6 p.Article

RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtypeONSY HABASHY, Hany; POWE, Desmond G; ELLIS, Ian O et al.Breast cancer research and treatment. 2011, Vol 128, Num 2, pp 315-326, issn 0167-6806, 12 p.Article

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancersABDEL-FATAH, Tarek M; POWE, Desmond G; AGBOOLA, Johnson et al.Journal of pathology (Print). 2010, Vol 220, Num 4, pp 419-434, issn 0022-3417, 16 p.Article

Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatmentsBARROS, Fabrício F. T; POWE, Desmond G; ELLIS, Ian O et al.Histopathology. 2010, Vol 56, Num 5, pp 560-572, issn 0309-0167, 13 p.Article

The expression of ERa, ERβ and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCRGREEN, Andrew R; YOUNG, Peter; KRIVINSKAS, Sophie et al.Histopathology. 2009, Vol 54, Num 4, pp 419-427, issn 0309-0167, 9 p.Article

  • Page / 2